9-78297199-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_058179.4(PSAT1):​c.-12G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.78 in 1,593,282 control chromosomes in the GnomAD database, including 486,704 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.79 ( 48248 hom., cov: 34)
Exomes 𝑓: 0.78 ( 438456 hom. )

Consequence

PSAT1
NM_058179.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.48
Variant links:
Genes affected
PSAT1 (HGNC:19129): (phosphoserine aminotransferase 1) This gene encodes a member of the class-V pyridoxal-phosphate-dependent aminotransferase family. The encoded protein is a phosphoserine aminotransferase and decreased expression may be associated with schizophrenia. Mutations in this gene are also associated with phosphoserine aminotransferase deficiency. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 1, 3, and 8. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 9-78297199-G-C is Benign according to our data. Variant chr9-78297199-G-C is described in ClinVar as [Benign]. Clinvar id is 367450.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-78297199-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.819 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PSAT1NM_058179.4 linkuse as main transcriptc.-12G>C 5_prime_UTR_variant 1/9 ENST00000376588.4 NP_478059.1
PSAT1NM_021154.5 linkuse as main transcriptc.-12G>C 5_prime_UTR_variant 1/8 NP_066977.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PSAT1ENST00000376588.4 linkuse as main transcriptc.-12G>C 5_prime_UTR_variant 1/91 NM_058179.4 ENSP00000365773 P1Q9Y617-1
PSAT1ENST00000347159.6 linkuse as main transcriptc.-12G>C 5_prime_UTR_variant 1/81 ENSP00000317606 Q9Y617-2

Frequencies

GnomAD3 genomes
AF:
0.795
AC:
120866
AN:
152086
Hom.:
48212
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.818
Gnomad AMI
AF:
0.709
Gnomad AMR
AF:
0.831
Gnomad ASJ
AF:
0.782
Gnomad EAS
AF:
0.674
Gnomad SAS
AF:
0.719
Gnomad FIN
AF:
0.811
Gnomad MID
AF:
0.785
Gnomad NFE
AF:
0.786
Gnomad OTH
AF:
0.786
GnomAD3 exomes
AF:
0.785
AC:
169160
AN:
215464
Hom.:
66798
AF XY:
0.779
AC XY:
91924
AN XY:
117966
show subpopulations
Gnomad AFR exome
AF:
0.822
Gnomad AMR exome
AF:
0.881
Gnomad ASJ exome
AF:
0.774
Gnomad EAS exome
AF:
0.675
Gnomad SAS exome
AF:
0.728
Gnomad FIN exome
AF:
0.801
Gnomad NFE exome
AF:
0.782
Gnomad OTH exome
AF:
0.789
GnomAD4 exome
AF:
0.779
AC:
1122336
AN:
1441078
Hom.:
438456
Cov.:
53
AF XY:
0.777
AC XY:
556246
AN XY:
716034
show subpopulations
Gnomad4 AFR exome
AF:
0.813
Gnomad4 AMR exome
AF:
0.874
Gnomad4 ASJ exome
AF:
0.781
Gnomad4 EAS exome
AF:
0.613
Gnomad4 SAS exome
AF:
0.731
Gnomad4 FIN exome
AF:
0.803
Gnomad4 NFE exome
AF:
0.783
Gnomad4 OTH exome
AF:
0.773
GnomAD4 genome
AF:
0.795
AC:
120958
AN:
152204
Hom.:
48248
Cov.:
34
AF XY:
0.795
AC XY:
59181
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.818
Gnomad4 AMR
AF:
0.831
Gnomad4 ASJ
AF:
0.782
Gnomad4 EAS
AF:
0.673
Gnomad4 SAS
AF:
0.721
Gnomad4 FIN
AF:
0.811
Gnomad4 NFE
AF:
0.786
Gnomad4 OTH
AF:
0.783
Alfa
AF:
0.796
Hom.:
8497
Bravo
AF:
0.800
Asia WGS
AF:
0.650
AC:
2263
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

PSAT deficiency Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Neu-Laxova syndrome 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.9
DANN
Benign
0.52
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2277148; hg19: chr9-80912115; COSMIC: COSV61301815; API